Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries

BACKGROUND: The chemical treatment of Plasmodium falciparum for human infections is losing efficacy each year due to the rise of resistance. One possible strategy to find novel anti-malarial drugs is to access the largest reservoir of genomic biodiversity source on earth present in metagenomes of en...

Descripción completa

Detalles Bibliográficos
Autores: Mongui, Álvaro, Pérez Llanos, Francy J., Yamamoto, Marcio M., Lozano, Marcela, Zambrano, Maria M., Portillo, Patricia del, Fernández Becerra, Carmen, Restrepo, Silvia, Portillo Obando, Hernando A. del, Junca, Howard
Tipo de recurso: artículo
Fecha de publicación:2015
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:163154
Acceso en línea:https://ddd.uab.cat/record/163154
https://dx.doi.org/urn:doi:10.1186/s12936-015-0748-6
Access Level:acceso abierto
Palabra clave:Malaria
Metagenomics
Functional screening
Anti-malarial drugs
Synthetic gene design
Dermaseptin 4
Bioluminescent Plasmodium falciparum
Descripción
Sumario:BACKGROUND: The chemical treatment of Plasmodium falciparum for human infections is losing efficacy each year due to the rise of resistance. One possible strategy to find novel anti-malarial drugs is to access the largest reservoir of genomic biodiversity source on earth present in metagenomes of environmental microbial communities. METHODS: A bioluminescent P. falciparum parasite was used to quickly detect shifts in viability of microcultures grown in 96-well plates. A synthetic gene encoding the Dermaseptin 4 peptide was designed and cloned under tight transcriptional control in a large metagenomic insert context (30 kb) to serve as proof-of-principle for the screening platform. RESULTS: Decrease in parasite viability consistently correlated with bioluminescence emitted from parasite microcultures, after their exposure to bacterial extracts containing a plasmid or fosmid engineered to encode the Dermaseptin 4 anti-malarial peptide. Here, a new technical platform to access the anti-malarial potential in microbial environmental metagenomes has been developed